Viewing Study NCT03408561


Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-01-03 @ 12:26 AM
Study NCT ID: NCT03408561
Status: WITHDRAWN
Last Update Posted: 2019-09-17
First Post: 2018-01-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer
Sponsor: University of Southern California
Organization:

Study Overview

Official Title: The Use of Social Media Listening for Targeted Recruitment of Twitter Users in LA County in Cancer Trials Compared to Historic Recruitment Data: A Mixed-Methods Study
Status: WITHDRAWN
Status Verified Date: 2019-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: No accrual
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This pilot clinical trial studies how well social media listening works in improving clinical trial recruitment in patients with cancer. Social media listening and recruitment on Twitter may enhance enrollment for cancer-related clinical trials.
Detailed Description: PRIMARY OBJECTIVES:

I. Examine the feasibility (acceptance among University of Southern California \[USC\] Norris study team members and Twitter users in Los Angeles \[LA\] county) of targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials.

II. Gain preliminary data on the impact (i.e., numbers recruited versus projected accrual compared to historic recruitment) of targeted social media listening (SML) as a tool for enhancing recruitment to cancer trials among Twitter users in LA county.

III. Estimate the effect size of the number of people enrolled associated with the use of targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials.

OUTLINE:

Patients who mention specific cancer disease keywords and/or hashtags are identified and receive a message via Twitter. Patients are then contacted for recruitment into a clinical trial.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2017-02145 REGISTRY CTRP (Clinical Trial Reporting Program) View
0S-17-7 OTHER USC / Norris Comprehensive Cancer Center View
P30CA014089 NIH None https://reporter.nih.gov/quic… View